896732-43-7

Basic information

• Product Name: 2-(3-(trifluoromethyl)phenoxy)tetrahydro-2H-pyran
• Synonyms: 2-(3-(trifluoromethyl)phenoxy)tetrahydro-2H-pyran
• CAS NO: 896732-43-7
• Molecular Weight: 246.229
• Mol File: 896732-43-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: 2-(3-(trifluoromethyl)phenoxy)tetrahydro-2H-pyran(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(3-(trifluoromethyl)phenoxy)tetrahydro-2H-pyran(896732-43-7)
• EPA Substance Registry System: 2-(3-(trifluoromethyl)phenoxy)tetrahydro-2H-pyran(896732-43-7)

Safety Data

• Hazardous Substances Data: 896732-43-7(Hazardous Substances Data)

Upstream product

• 142-68-7 TETRAHYDROPYRANE 
• 98-17-9 3-Trifluoromethylphenol 
• 110-87-2 3,4-dihydro-2H-pyran 

Downstream Products

• 219714-96-2 penoxsulam 
• 865352-01-8 2-(2',2'-difluoroethoxy)-6-trifluoromethylbenzene-1-sulfonyl chloride 
• 924647-38-1 1-(2,2-difluoroethoxy)-2-(propylsulphanyl)-3-(trifluoromethyl)benzene 
• 58914-34-4 2-hydroxy-4-(trifluoromethyl)benzaldehyde 

Relevant articles and documents

TRANSCRIPTION FACTOR BRN2 INHIBITORY COMPOUNDS AS THERAPEUTICS AND METHODS FOR THEIR USE

The invention provides a variety of compounds having the structure of Formula I and uses of such compounds for treatment of various indications, including cancer as well as methods of treatment involving such compounds are also provided. The uses of the compounds may specifically include: bladder cancer, cholangiocarcinoma; colorectal cancer; diffuse large B-cell lymphoma (DLBC); liver cancer; ovarian cancer; thymoma; thyroid cancer; clear cell renal cell carcinoma (CCRCC); chromophobe renal cell carcinoma (ChRCC); prostate cancer; breast cancer; uterine cancer; pancreatic cancer; cervical cancer; uveal melanoma; acute myeloid leukemia (AML); head and neck cancer; small cell lung cancer (SCLC); lung adenocarcinoma sarcoma; mesothelioma; adenoid cystic carcinoma (ACC), sarcoma; testicular germ cell cancer; uterine cancer; pheochromocytoma and paraganglioma (PCPG); melanoma; glioma; glioblastoma multiforme; T-cell Acute Lymphoblastic Leukemia; T-cell Lympohoma, medulloblastoma; and neuroblastoma.

2 - phenoxy four hydrogens fu ([...]) five fluorine sulphur grass amine[...] derivatives and their application in the synthesis of

The invention discloses 2-phenoxyl tetrahydrofuran (tetrahydropyrane) derivatives and the application thereof in synthesis of penoxsulam, and belongs to the field of pesticide synthesis. A new intermediate of a penoxsulam pesticide is synthesized by the derivatives of the design of the invention. A high-toxicity raw material is not required to be used in the preparation of the intermediate; a product is convenient to purify and high in yield; a synthesizing process is environment-friendly; the synthesis cost is low. The penoxsulam pesticide can be prepared conveniently by utilizing the intermediate; the intermediate has a good application prospect. The series of derivatives are easy and convenient to synthesize; compared with the reported penoxsulam intermediate, a low-boiling-point raw material with high toxicity, namely, chloromethyl methyl ether, is not required to be used in the synthesizing process; the safety of the synthesizing process is improved; the derivatives are favorable to industrialized production and application.

AMIDE DERIVATIVES AS ION-CHANNEL LIGANDS AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by w